Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 26

Related Articles by Review for PubMed (Select 21633595)

1.

Silybin and the liver: from basic research to clinical practice.

Loguercio C, Festi D.

World J Gastroenterol. 2011 May 14;17(18):2288-301. doi: 10.3748/wjg.v17.i18.2288. Review.

4.

Hepatoprotective herbal drug, silymarin from experimental pharmacology to clinical medicine.

Pradhan SC, Girish C.

Indian J Med Res. 2006 Nov;124(5):491-504. Review.

PMID:
17213517
5.

Silybin and silymarin--new and emerging applications in medicine.

Gazák R, Walterová D, Kren V.

Curr Med Chem. 2007;14(3):315-38. Review.

PMID:
17305535
6.

Silymarin: a review of its clinical properties in the management of hepatic disorders.

Wellington K, Jarvis B.

BioDrugs. 2001;15(7):465-89. Review.

PMID:
11520257
7.

Milk thistle in liver diseases: past, present, future.

Abenavoli L, Capasso R, Milic N, Capasso F.

Phytother Res. 2010 Oct;24(10):1423-32. doi: 10.1002/ptr.3207. Review.

PMID:
20564545
8.

Silybin and silymarin--new effects and applications.

Kren V, Walterová D.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):29-41. Review.

9.

Milk thistle (Silybum marianum) for the therapy of liver disease.

Flora K, Hahn M, Rosen H, Benner K.

Am J Gastroenterol. 1998 Feb;93(2):139-43. Review.

PMID:
9468229
10.

An updated systematic review of the pharmacology of silymarin.

Saller R, Melzer J, Reichling J, Brignoli R, Meier R.

Forsch Komplementmed. 2007 Apr;14(2):70-80. Epub 2007 Apr 23. Review.

PMID:
17464157
11.

Recent advances in the nanotechnology-based drug delivery of Silybin.

Wang Y, Zhang L, Wang Q, Zhang D.

J Biomed Nanotechnol. 2014 Apr;10(4):543-58. Review.

PMID:
24734507
12.

Chemistry of silybin.

Biedermann D, Vavříková E, Cvak L, Křen V.

Nat Prod Rep. 2014 Sep;31(9):1138-57. doi: 10.1039/c3np70122k. Review.

PMID:
24977260
13.

Advances in pharmacological studies of silymarin.

Rui YC.

Mem Inst Oswaldo Cruz. 1991;86 Suppl 2:79-85. Review.

14.

Biotransformation of silybin and its congeners.

Křen V, Marhol P, Purchartová K, Gabrielová E, Modrianský M.

Curr Drug Metab. 2013 Dec;14(10):1009-21. Review.

PMID:
24261705
15.

Toward the definition of the mechanism of action of silymarin: activities related to cellular protection from toxic damage induced by chemotherapy.

Comelli MC, Mengs U, Schneider C, Prosdocimi M.

Integr Cancer Ther. 2007 Jun;6(2):120-9. Review.

PMID:
17548791
16.

Drug-drug interactions of silymarin on the perspective of pharmacokinetics.

Wu JW, Lin LC, Tsai TH.

J Ethnopharmacol. 2009 Jan 21;121(2):185-93. doi: 10.1016/j.jep.2008.10.036. Epub 2008 Nov 8. Review.

PMID:
19041708
17.

Milk thistle nomenclature: why it matters in cancer research and pharmacokinetic studies.

Kroll DJ, Shaw HS, Oberlies NH.

Integr Cancer Ther. 2007 Jun;6(2):110-9. Review.

PMID:
17548790
18.

Potential renoprotective effects of silymarin against nephrotoxic drugs: a review of literature.

Dashti-Khavidaki S, Shahbazi F, Khalili H, Lessan-Pezeshki M.

J Pharm Pharm Sci. 2012;15(1):112-23. Review.

19.

Milk thistle and the treatment of hepatitis.

Giese LA.

Gastroenterol Nurs. 2001 Mar-Apr;24(2):95-7. Review.

PMID:
11847735
20.

Herbal medicine in the treatment of liver diseases.

Stickel F, Schuppan D.

Dig Liver Dis. 2007 Apr;39(4):293-304. Epub 2007 Feb 28. Review.

PMID:
17331820
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk